SmartMetric (SMME) 10-Q 14 Feb 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Dec. 31, 2019	Feb. 14, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	SmartMetric, Inc.
Entity Central Index Key	0001301991
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Type	10-Q
Document Period End Date	Dec. 31, 2019
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2020
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Interactive Data Current	No
Entity File Number	000-54853
Entity Incorporation State Country Code	NV
Entity Common Stock, Shares Outstanding		312,936,217

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Jun. 30, 2019
Current assets:
Cash	$ 53,473	$ 10,161
Prepaid expenses and other current assets	13,017	6,450
Total current assets	66,490	16,611
Total assets	66,490	16,611
Current liabilities:
Accounts payable and accrued expenses	891,398	884,140
Liability for stock to be issued	189,538	147,484
Deferred Officer's salary	790,015	790,015
Related party interest payable	121,138	93,488
Dividends payable	4,374	3,123
Due to shareholders	41,343
Shareholder loan	9,819	3,759
Total current liabilities	2,047,625	1,922,009
Commitments and Contingencies (Note 4)
Series C mandatory redeemable convertible preferred stock, net of discount, authorized 1,000,000 shares 106,800 and 121,700 shares issued and outstanding, respectively	86,564	99,278
Stockholders' deficit:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 610,000 and 610,000 shares issued and outstanding	610	610
Common stock, $.001 par value; 600,000,000 and 300,000,000 shares authorized, 281,965,822 and 264,648,821 shares issued and outstanding , respectively	281,966	264,649
Additional paid-in capital	25,051,083	24,663,528
Accumulated deficit	(27,401,358)	(26,933,463)
Total stockholders' deficit	(2,067,699)	(2,004,676)
Total liabilities and stockholders' deficit	$ 66,490	$ 16,611

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Jun. 30, 2019
Preferred stock, par value	$ .001	$ .001
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	610,000	610,000
Preferred stock, outstanding	610,000	610,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	600,000,000	300,000,000
Common stock, issued	281,965,822	264,648,821
Common stock, outstanding	281,965,822	264,648,821
Series C mandatory redeemable convertible preferred stock
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued	106,800	121,700
Preferred stock, outstanding	106,800	121,700

Condensed Consolidated Statemen

Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenues
Expenses:
Officer's salary	47,500	47,500	95,000	95,000
Other general and administrative	149,719	124,157	282,578	248,161
Research and development	25,594	21,775	46,706	51,135
Total operating expenses	222,813	193,432	424,284	394,296
Loss from operations before other expense	(222,813)	(193,432)	(424,284)	(394,296)
Other expense
Interest expense	(13,825)	(13,358)	(27,651)	(25,820)
Total other expense	(13,825)	(13,358)	(27,651)	(25,820)
Loss before income taxes	(236,638)	(206,790)	(451,935)	(420,116)
Provision for income taxes
Net loss	(236,638)	(206,790)	(451,935)	(420,116)
Preferred stock dividends	(4,238)		(15,963)
Net loss available for common stockholders	$ (240,876)	$ (206,790)	$ (467,898)	$ (420,116)
Net loss per share, basic and diluted	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares outstanding, basic and diluted	278,034,075	254,804,287	275,362,668	252,521,874

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Changes In Stockholders' (Deficit) (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Jun. 30, 2018		$ 249,148	$ 24,217,831	$ (25,996,910)	$ (1,529,321)
Balance, Shares at Jun. 30, 2018		249,147,547
Shares issued of common stock and warrants for cash		$ 5,503	210,667		216,170
Shares issued of common stock and warrants for cash, shares		5,502,538
Net loss for the period				(213,827)	(213,827)
Balance at Sep. 30, 2018		$ 254,651	24,428,498	(26,210,237)	(1,526,479)
Balance, shares at Sep. 30, 2018		254,650,085
Balance at Jun. 30, 2018		$ 249,148	24,217,831	(25,996,910)	(1,529,321)
Balance, Shares at Jun. 30, 2018		249,147,547
Net loss for the period					(260,270)
Balance at Dec. 31, 2018		$ 256,678	24,479,000	(26,417,027)	(1,680,740)
Balance, shares at Dec. 31, 2018		256,676,745
Balance at Sep. 30, 2018		$ 254,651	24,428,498	(26,210,237)	(1,526,479)
Balance, Shares at Sep. 30, 2018		254,650,085
Shares issued of common stock and warrants for cash		$ 2,027	59,973		62,000
Shares issued of common stock and warrants for cash, shares		2,026,660
Net loss available for common shareholders					(206,790)
Apic Adjustment			(9,471)		(9,471)
Net loss for the period				(206,790)	(206,790)
Balance at Dec. 31, 2018		$ 256,678	24,479,000	(26,417,027)	(1,680,740)
Balance, shares at Dec. 31, 2018		256,676,745
Balance at Jun. 30, 2019	$ 610	$ 264,649	24,663,528	(26,933,461)	(2,004,676)
Balance, Shares at Jun. 30, 2019	610,000	264,648,821
Shares issued of common stock and warrants for cash		$ 7,992	218,008		226,000
Shares issued of common stock and warrants for cash, shares		7,991,662
Shares converted from Preferred shares		$ 3,224	63,289		66,513
Shares converted from Preferred shares, shares		3,224,643
Preferred Dividends				(11,725)	(11,725)
Net loss available for common shareholders				(215,296)	(215,296)
Balance at Sep. 30, 2019	$ 610	$ 275,865	24,944,825	(27,160,482)	(1,939,182)
Balance, shares at Sep. 30, 2019	610,000	275,865,126
Balance at Jun. 30, 2019	$ 610	$ 264,649	24,663,528	(26,933,461)	(2,004,676)
Balance, Shares at Jun. 30, 2019	610,000	264,648,821
Net loss for the period					(451,935)
Balance at Dec. 31, 2019	$ 610	$ 281,966	25,051,083	(27,401,358)	(2,067,699)
Balance, shares at Dec. 31, 2019	610,000	281,965,822
Balance at Sep. 30, 2019	$ 610	$ 275,865	24,944,825	(27,160,482)	(1,939,182)
Balance, Shares at Sep. 30, 2019	610,000	275,865,126
Shares issued of common stock and warrants for cash		$ 3,730	77,720		81,450
Shares issued of common stock and warrants for cash, shares		3,730,000
Shares converted from Preferred shares		$ 2,371	28,538		30,909
Shares converted from Preferred shares, shares		2,370,696
Preferred Dividends				(4,238)	(4,238)
Net loss available for common shareholders				(236,638)	(240,876)
Net loss for the period					(236,638)
Balance at Dec. 31, 2019	$ 610	$ 281,966	$ 25,051,083	$ (27,401,358)	$ (2,067,699)
Balance, shares at Dec. 31, 2019	610,000	281,965,822

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (451,935)	$ (260,270)
Changes in assets and liabilities
Increase in prepaid expenses and other current assets	(6,567)	4,750
Increase (decrease) in accounts payable and accrued expenses	7,258	38,529
Increase in deferred officer salary		95,000
Increase in credit card debt		1,313
Increase in due to shareholder	41,343
Increase in accrued interest payable	27,650	25,821
Net cash used in operating activities	(382,251)	(94,857)
CASH FLOWS FROM FINANCING ACTIVITIES
Loans from related parties	6,060	3,520
Proceeds from sale of common stock	349,504	251,829
Proceeds from sale of Series C Preferred stock	70,000
Net cash provided by financing activities	425,564	255,349
NET INCREASE IN CASH	43,312	160,492
CASH, BEGINNING OF PERIOD	10,161	4,427
CASH, END OF PERIOD	53,473	164,919
CASH PAID DURING THE PERIOD FOR:
Income taxes
Interest
Non-cash financing and investing activities
Conversion of 104,000 Preferred C shares into 5,595,339 shares of Common stock	$ 93,906

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Parenthetical)	6 Months Ended
	Dec. 31, 2019shares
Common Stock [Member]
Conversion of shares	5,595,339
Series C Preferred Shares [Member]
Conversion of shares	104,000

Organization and Basis of Prese

Organization and Basis of Presentation	6 Months Ended
	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION SmartMetric, Inc. (“SmartMetric” or the “Company”) was incorporated pursuant to the laws of Nevada on December 18, 2002. SmartMetric is a company engaged in the technology industry. SmartMetric’s main products are a fingerprint sensor activated payments card and a security card with a finger sensor and fully functional fingerprint reader embedded inside the card. The SmartMetric biometric cards have a rechargeable battery allowing for portable biometric identification and card activation. This card is referred to as a biometric card or the SmartMetric Biometric Card. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management of the Company, the accompanying unaudited financial statements contain all the adjustments (which are of a normal recurring nature) necessary for a fair presentation. Operating results for the six months ended December 31, 2019 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020. For further information, refer to the financial statements and the footnotes thereto contained in the Company’s Annual Report on Form 10-K for the year ended June 30, 2019, as filed with the Securities and Exchange Commission on September 30, 2019. The condensed consolidated balance sheet as of June 30, 2019, has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by US GAAP for complete financial statements. Going Concern As shown in the accompanying condensed consolidated financial statements the Company has sustained recurring losses of $451,935 and $420,116 for the six months ended December 31, 2019 and 2018, respectively, and has an accumulated deficit of $27,401,358 at December 31, 2019. There are no assurances that the Company will be able to achieve the level of revenues adequate to generate sufficient cash flow from operations to support the Company’s working capital requirements. To the extent that funds generated are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available, the Company may not continue its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date of this filing. The financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management believes that the Company’s capital requirements will depend on many factors. These factors include product marketing and distribution. The management plans include equity sales and borrowing in order to fund the operations. Principles of Consolidation The condensed consolidated financial statements do not include any adjustments relating to the carrying amounts of recorded assets or the carrying amounts and classification of recorded liabilities that may be required should the Company be unable to continue as a going concern. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Actual results may differ from those estimates. Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs. Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow except as noted below. In February 2016, the FASB issued authoritative guidance, which is included in ASC 842, “Leases.” This guidance requires lessees to recognize most leases on the balance sheet by recording a right-of-use asset and a lease liability. The Company has made the decision to adopt this guidance early, making it effective for the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment will not have a material impact on the financial statements. In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity—Equity-Based Payments to Non-Employees. This guidance is effective for the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment will not have a material impact on the financial statements. Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2019 and 2018, 28,153,406 and 20,257,155 dilutive shares were excluded from the calculation of diluted loss per common share, with all dilutive shares being Common stock warrants. Stock-Based Compensation The Company measures expense for issuances of stock-based compensation to employees and others at fair value of the stock and warrants issued, as this is more reliable than the fair value of the services received complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital. Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

Prepaid Expenses

Prepaid Expenses	6 Months Ended
	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSES	NOTE 3 PREPAID EXPENSES Prepaid expenses represent the unexpired terms of various consulting agreements as well as advance rental payments. The Company does not currently have any prepaid items related to shares issue for services.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4 - COMMITMENTS AND CONTINGENCIES Lease Agreement The Company's main office is located in Las Vegas, Nevada. Rent expense under all leases for the six months ended December 31, 2019 and 2018 was $2,303 and $7,277 respectively. The Company maintains only one office. This office is located in Las Vegas, NV and is a month-to-month lease. Related Party Transactions The Company's Chief Executive Officer has made cash advances to the Company with an aggregate amount due of $9,819 and $3,759 at December 31, 2019 and June 30, 2019, respectively. These advances bear interest at the rate of five percent (5%) per annum. The Company has accrued the amounts of $790,015 and $790,015 at December 31, 2019 and June 30, 2019, respectively, as deferred officer's salary, for the difference between the Chief Executive Officer's annual salary and the amounts paid. On September 11, 2017, we received a license to certain patents from Chaya Hendrick, our founder and CEO, related to our technologies until the expiration of the patents. As consideration, we issued Chaya Hendrick, or her assigns, (i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.

Stockholders' Deficit

Stockholders' Deficit	6 Months Ended
	Dec. 31, 2019
Equity [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 5 STOCKHOLDERS' DEFICIT Preferred Stock As of December 31, 2019, the Company has 5,000,000 shares of Class B preferred stock, par value $0.001, authorized and 610,000 shares issued and outstanding. On December 11, 2009, the Company filed a Certificate of Designation with the State of Nevada, to designate 500,000 shares of preferred stock as Series B Convertible Preferred Stock ("Series B Convertible Preferred Stock"). Effective November 5, 2014, the number of shares designated as Series B Convertible Preferred Stock was increased to 5,000,000 shares. Each share of Series B Convertible Preferred Stock has a par value of $0.001, and a stated value equal to $5.00 ("Stated Value"). Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert each share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock. Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock. Class A Common Stock As of December 31, 2019, the Company has 50,000,000 shares of Class A common stock, par value $0.001, authorized and no shares issued and outstanding. In October 2003, the Company issued 50,000,000 shares of Class A common stock at par value ($50,000). These shares were converted into 50,000,000 shares of common stock in 2006. Common Stock The Company was incorporated on December 18, 2002, with 45,000,000 shares of Common Stock, par value $0.001, authorized. The Articles of Incorporation were amended in 2006 to increase the number of authorized shares to 100,000,000 shares, and in 2009 to increase the number of authorized shares to 200,000,000. As a result of a screener's error, the Company previously disclosed in its Quarterly Report on Form 10-Q for the quarters ended September 30, 2015 and December 31, 2015 that it increased the number of authorized shares of common stock to 300,000,000. On March 31, 2016, our Board of Directors ("The Board") approved an amendment (the "Amendment") to the Company's Articles of Incorporation to increase the total number of shares of authorized capital stock to 305,000,000 shares, par value $0.001 per share, consisting of (i) 300,000,000 shares of Common Stock, up from 200,000,000 shares of Common Stock, and (ii) 5,000,000 shares of Preferred Stock, subject to shareholder approval (the "Proposal"). On March 31, 2016, a majority of the Company's stockholders approved the Amendment. The Company filed a definitive information statement on Schedule 14C with the Securities and Exchange Commission on May 4, 2016 (the "Information Statement"). The Information Statement was furnished to all of the Company's shareholders for the purpose of informing them of the action taken by a majority of the Company's stockholders. During the three month period ending December 31, 2019, the Company increased its total number of shares of authorized capital stock to 600,000,000 shares, par value $0.001 per share. As of December 31, 2019, the Company has 281,965,822 shares of common stock issued and outstanding. ● During the three months ended September 30, 2019, the Company sold for cash 6,337,500 shares of common stock and warrants to purchase: (i) 6,337,500 shares at prices ranging from $0.10 per share to $0.25 per share for net proceeds of $133,495. The warrants expire at various times through September 17, 2021. None of these shares were issued during the quarter ended September 30, 2019, with all 6,337,500 shares being recorded as stock payable. During the three months ended September 30, 2019, the Company issued 11,216,305 shares for cash. Of these shares, 7,991,662 shares were issued from stock payable. There were 52,800 Preferred C shares issued for net proceeds of $45,000 and 70,000 Preferred C shares converted to 3,224,643 Common shares for the three month period ended September 30, 2019 ● During the three months ended December 31, 2019, the Company sold for cash 40,675,000 shares of common stock and warrants to purchase: (i) 825,000 shares at prices ranging from $0.20 per share to $0.25 per share for net proceeds of $214,510. The warrants expire at various times through November 1, 2021. None of these shares were issued during the quarter ended December 31, 2019, with all 40,675,000 shares being recorded as stock payable. During the three months ended December 31, 2019, the Company issued 3,730,000 shares for cash. Of these shares, all of these were issued from stock liability. There were 36,300 Preferred C shares issued for net proceeds of $25,000 and 34,000 Preferred C shares converted to 2,370,696 Common shares for the three month period ended December 31, 2019. Warrants From time to time the Company granted warrants in connection with private placements of securities, as described herein. As of December 31, 2019, and June 30, 2019, the following is a breakdown of the warrant activity: Range of Exercise Prices Number of Weighted-Average Weighted- Number Weighted- Warrants Outstanding and Exercisable at December 31, 2019: $0.05 - $1.00 28,153,406 1.27 $ 0.28 28,153,406 $ 0.28 Warrants Outstanding and Exercisable at June 30, 2019: $0.20 - $1.00 26,526,234 1.12 $ 0.34 26,526,234 $ 0.34 Warrant Activity: December 31, 2019: Outstanding - June 30, 2019 26,526,234 Issued 7,162,500 Exercised — Expired (5,535,328 ) Outstanding - December 31, 2019 28,153,406 June 30, 2019: Outstanding - June 30, 2018 14,842,583 Issued 18,738,235 Exercised — Expired (7,054,584 ) Outstanding - June 30, 2019 26,526,234 At December 31, 2019, all of the 28,153,406 warrants are vested and (i) 27,853,406 warrants expire at various times prior to November 1, 2021, (ii) 300,000 warrants expire in July 2020,

Mandatory Redeemable Convertibl

Mandatory Redeemable Convertible Preferred Stock	6 Months Ended
	Dec. 31, 2019
Mandatory Redeemable Convertible Preferred Stock [Abstract]
MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK	NOTE 6 MANDATORY REDEEMABLE CONVERTIBLE PREFERRED STOCK Issuances of Series C Mandatory Redeemable Convertible Preferred Stock On January 10, 2019, the Board of Directors of the Company adopted a resolution pursuant to the Company's Certificate of Incorporation, as amended, providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions, of the Series C Convertible Preferred Stock. On January 14, 2019, the Company filed a Certificate of Designations for a Series C Convertible Preferred Stock. The authorized number of Series C Convertible Preferred Stock is 1,000,000 shares, par value 0.001. The Series C Preferred Stock will, with respect to dividend rights and rights upon liquidation, winding-up or dissolution, rank: (a) senior with respect to dividends and right of The number of Series C, mandatory redeemable convertible preferred stock shares issued and outstanding were 106,800 and 121,700, respectively, for December 31, 2019 and June 30, 2019. The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The "Variable Conversion Price" shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). "Market Price" means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. On the date which is eighteen (18) months following the Issuance Date or upon the occurrence of an Event of Default (the "Mandatory Redemption Date"), the Company shall redeem all of the shares of Series C Preferred Stock of the Holder (which have not been previously redeemed or converted). With five (5) days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to the total number of shares of Series C Preferred Stock held by such Holder multiplied by the then current Stated Value. All shares of mandatorily redeemable convertible preferred stock have been presented outside of permanent equity in accordance with ASC 480, Classification and Measurement of Redeemable Securities The estimated fair value of the Series C mandatory redeemable convertible preferred stock at December 31, 2019 and 2018 was $86,568 and $0, respectively. There were 36,300 Preferred C shares issued for net proceeds of $25,000 and 34,000 Preferred C shares converted to 2,370,696 Common shares for the three month period ended December 31, 2019. For the six month period ended December 31, 2019, there were 89,100 Preferred C shares issued for net proceeds of $70,000 and 104,000 Preferred C shares converted to 5,595,339 Common shares.

Income Taxes

Income Taxes	6 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 7 INCOME TAXES The Company provides for income taxes at the end of each interim period based on the estimated effective tax rate for the full fiscal year. Cumulative adjustments to the Company's estimate are recorded in the interim period in which a change in the estimated annual effective rate is determined. The Company has estimated its effective tax rate to be 0%, based primarily on losses incurred and the uncertainty of realization of the tax benefit of such losses.

Litigation

Litigation	6 Months Ended
	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	NOTE 8 LITIGATION From time to time we may be a defendant or plaintiff in various legal proceedings arising in the normal course of our business. As of the date of this Quarterly Report, there are no material pending legal or governmental proceedings relating to us or properties to which we are a party, and, to our knowledge, there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.

Subsequent Events

Subsequent Events	6 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2019 to the date these financial statements were issued. On January 16, 2020, the Company converted 17,700 preferred shares into 2,445,395 common shares. The Company issued 28,525,000 shares for cash for $570,500.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Actual results may differ from those estimates.
Research and Development	Research and Development Research and development costs are charged to expense as incurred. Our research and development expenses consist primarily of expenditures for electronics design and engineering, software design and engineering, component sourcing, component engineering, manufacturing, product trials, compensation and consulting costs.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow except as noted below. In February 2016, the FASB issued authoritative guidance, which is included in ASC 842, “Leases.” This guidance requires lessees to recognize most leases on the balance sheet by recording a right-of-use asset and a lease liability. The Company has made the decision to adopt this guidance early, making it effective for the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment will not have a material impact on the financial statements. In June 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity—Equity-Based Payments to Non-Employees. This guidance is effective for the Company as of March 1, 2019. Based on the completed analysis, the Company has determined the adjustment will not have a material impact on the financial statements.
Loss Per Share of Common Stock	Loss Per Share of Common Stock In accordance with FASB ASC 260, “Earnings Per Share,” the basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Basic net loss per share excludes the dilutive effect of stock options or warrants and convertible notes. Diluted net earnings (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2019 and 2018, 28,153,406 and 20,257,155 dilutive shares were excluded from the calculation of diluted loss per common share.
Stock-Based Compensation	Stock-Based Compensation The Company measures expense for issuances of stock-based compensation to employees and others at fair value of the stock and warrants issued, as this is more reliable than the fair value of the services received complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	6 Months Ended
	Dec. 31, 2019
Stockholders' Equity Note [Abstract]
Schedule of share based compensation warrant activity	Range of Exercise Prices Number of Weighted-Average Weighted- Number Weighted- Warrants Outstanding and Exercisable at December 31, 2019: $0.05 - $1.00 28,153,406 1.27 $ 0.28 28,153,406 $ 0.28 Warrants Outstanding and Exercisable at June 30, 2019: $0.20 - $1.00 26,526,234 1.12 $ 0.34 26,526,234 $ 0.34 Warrant Activity: December 31, 2019: Outstanding - June 30, 2019 26,526,234 Issued 7,162,500 Exercised — Expired (5,535,328 ) Outstanding - December 31, 2019 28,153,406 June 30, 2019: Outstanding - June 30, 2018 14,842,583 Issued 18,738,235 Exercised — Expired (7,054,584 ) Outstanding - June 30, 2019 26,526,234

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019
Organization and Basis of Presentation (Textual)
Net loss	$ (236,638)	$ (206,790)	$ (451,935)	$ (420,116)
Accumulated deficit	$ (27,401,358)		$ (27,401,358)		$ (26,933,463)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - shares	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Summary of Significant Accounting Policies (Textual)
Dilutive shares were excluded from diluted loss per common share	28,153,406	20,257,155

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Sep. 11, 2019	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019
Commitments and Contingencies (Textual)
Rent expense		$ 2,303	$ 7,277
Deferred compensation liability		790,015		$ 790,015
Chief Executive Officer [Member]
Commitments and Contingencies (Textual)
Cash advances from related party		$ 9,819		$ 3,759
Interest rate		5.00%
Related party transactions, description	(i) 200,000 shares of Series B Convertible Preferred Stock, (ii) a royalty equal to 5% of gross revenues derived from products sold related to the patents, and (iii) certain minimum required payments beginning at $50,000 and doubling each year thereafter. The Series B Preferred Shares may be converted at the election of holder on a basis for 50 common shares for each preferred share at any time or an aggregate of 10,000,000 common shares in exchange for all 200,000 preferred shares.

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - Warrant [Member] - shares	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Abstract]
Outstanding - beginning of year		14,842,583
Issued	7,162,500	18,738,235
Exercised
Expired	(5,535,328)	(7,054,584)
Outstanding - end of year	28,153,406	26,526,234

Stockholders' Deficit (Details

Stockholders' Deficit (Details 1) - Warrant [Member] - $ / shares	6 Months Ended	12 Months Ended
	Dec. 31, 2019	Jun. 30, 2019
$0.05 - $1.00 [Member]
Warrants Outstanding and Exercisable at December 31, 2019:
Number of Warrants Outstanding	28,153,406
Weighted-Average Contractual Life Remining in Years	1 year 3 months 8 days
Weighted-average exercise price	$ 0.28
Number Exercisable	28,153,406
$0.05 - $1.00 [Member] | Minimum [Member]
Warrants Outstanding and Exercisable at December 31, 2019:
Exercise Price	$ 0.05
$0.05 - $1.00 [Member] | Maximum [Member]
Warrants Outstanding and Exercisable at December 31, 2019:
Exercise Price	$ 1
$0.20 - $1.00 [Member]
Warrants Outstanding and Exercisable at December 31, 2019:
Number of Warrants Outstanding		26,526,234
Weighted-Average Contractual Life Remining in Years		1 year 1 month 13 days
Weighted-average exercise price		$ 0.34
Number Exercisable		26,526,234
$0.20 - $1.00 [Member] | Minimum [Member]
Warrants Outstanding and Exercisable at December 31, 2019:
Exercise Price		$ 0.20
$0.20 - $1.00 [Member] | Maximum [Member]
Warrants Outstanding and Exercisable at December 31, 2019:
Exercise Price		$ 1

Stockholders' Deficit (Detail_2

Stockholders' Deficit (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Oct. 31, 2003	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Jun. 30, 2019	Nov. 05, 2014	Dec. 11, 2009	Jun. 30, 2006
Stockholders' Deficit (Textual)
Preferred stock, shares authorized		5,000,000		5,000,000		5,000,000
Preferred stock, par value		$ .001		$ .001		$ .001
Preferred stock, shares issued		610,000		610,000		610,000
Preferred stock, shares outstanding		610,000		610,000		610,000
Common stock, par value		$ 0.001		$ 0.001		$ 0.001
Common stock, shares authorized		600,000,000		600,000,000		300,000,000
Common stock, shares issued		281,965,822		281,965,822		264,648,821
Common stock, shares outstanding		281,965,822		281,965,822		264,648,821
Shares were converted into shares of common stock	50,000,000
Number of shares of authorized capital stock									50,000,000
Shares of common stock sold for cash		40,675,000	6,337,500
Common stock for net proceeds		$ 251,829	$ 446,072	$ 349,504	$ 251,829
Warrants to purchase shares, description		The Company sold for cash 40,675,000 shares of common stock and warrants to purchase: (i) 825,000 shares at prices ranging from $0.20 per share to $0.25 per share for net proceeds of $214,510. The warrants expire at various times through November 1, 2021. None of these shares were issued during the quarter ended December 31, 2019, with all 40,675,000 shares being recorded as stock payable. During the three months ended December 31, 2019, the Company issued 3,730,000 shares for cash. Of these shares, all of these were issued from stock liability. There were 36,300 Preferred C shares issued for net proceeds of $25,000 and 34,000 Preferred C shares converted to 2,370,696 Common shares for the three month period ended December 31, 2019.	The Company sold for cash 6,337,500 shares of common stock and warrants to purchase: (i) 6,337,500 shares at prices ranging from $0.10 per share to $0.25 per share for net proceeds of $133,495. The warrants expire at various times through September 17, 2021. None of these shares were issued during the quarter ended September 30, 2019, with all 6,337,500 shares being recorded as stock payable. During the three months ended September 30, 2019, the Company issued 11,216,305 shares for cash. Of these shares, 7,991,662 shares were issued from stock payable. There were 52,800 Preferred C shares issued for net proceeds of $45,000 and 70,000 Preferred C shares converted to 3,224,643 Common shares for the three month period ended September 30, 2019
Warrant [Member]
Stockholders' Deficit (Textual)
Number of warrants vested				28,153,406
Warrants expire		Nov. 1, 2021		Nov. 1, 2021
Number of warrants		$ 27,853,406		$ 27,853,406
Warrant One [Member]
Stockholders' Deficit (Textual)
Warrants expire		Jul. 31, 2020		Jul. 31, 2020
Number of warrants		$ 300,000		$ 300,000
Series C Convertible Preferred Stock [Member]
Stockholders' Deficit (Textual)
Designate share of preferred stock		1,000,000		1,000,000
Convertible preferred stock		500,000		500,000
Class B preferred stock [Member]
Stockholders' Deficit (Textual)
Preferred stock, shares authorized		5,000,000		5,000,000
Preferred stock, par value		$ 0.001		$ 0.001
Preferred stock, shares issued		610,000		610,000
Preferred stock, shares outstanding		610,000		610,000
Preferred designate shares								500,000
Class A Common Stock
Stockholders' Deficit (Textual)
Common stock, par value		$ 0.001		$ 0.001
Common stock, shares authorized		50,000,000		50,000,000
Common stock, shares issued
Common stock, shares outstanding
Common Stock [Member]
Stockholders' Deficit (Textual)
Common stock, par value		$ 0.001		$ 0.001
Common stock, shares authorized		45,000,000		45,000,000
Authorized Common stock, description				The Articles of Incorporation were amended in 2006 to increase the number of authorized shares to 100,000,000 shares, and in 2009 to increase the number of authorized shares to 200,000,000. As a result of a screener's error, the Company previously disclosed in its Quarterly Report on Form 10-Q for the quarters ended September 30, 2015 and December 31, 2015 that it increased the number of authorized shares of common stock to 300,000,000. On March 31, 2016, our Board of Directors ("The Board") approved an amendment (the "Amendment") to the Company's Articles of Incorporation to increase the total number of shares of authorized capital stock to 305,000,000 shares, par value $0.001 per share, consisting of (i) 300,000,000 shares of Common Stock, up from 200,000,000 shares of Common Stock, and (ii) 5,000,000 shares of Preferred Stock, subject to shareholder approval (the "Proposal"). On March 31, 2016, a majority of the Company's stockholders approved the Amendment.
Series B Convertible Preferred Stock [Member]
Stockholders' Deficit (Textual)
Convertible preferred stock							5,000,000

Mandatory Redeemable Converti_2

Mandatory Redeemable Convertible Preferred Stock (Details) - USD ($)	Jan. 14, 2019	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Preferred stock, authorized		5,000,000	5,000,000
Preferred stock, par value		$ .001	$ .001
Preferred stock shares issued		610,000	610,000
Preferred stock shares outstanding		610,000	610,000
Series C mandatory redeemable convertible preferred stock [Member]
Fair value of convertible preferred stock		$ 86,568		$ 0
Preferred stock, authorized	1,000,000
Preferred stock, par value	$ 0.001
Dividend percent	10.00%
Description of conversion of stock		The Holder shall have the right at any time during the period beginning on the date which is six (6) months following the Issuance Date, to convert all or any part of the outstanding Series C Preferred Stock into fully paid and non-assessable shares of Common Stock at the Variable Conversion Price. The “Variable Conversion Price” shall mean 71% multiplied by the Market Price (representing a discount rate of 29%). “Market Price” means the average of the two (2) lowest Trading Prices (as defined here) for the Common Stock during the fifteen (15) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date.
Preferred stock shares issued		106,800	121,700
Preferred stock shares outstanding		106,800	121,700
Preferred shares, description		There were 36,300 Preferred C shares issued for net proceeds of $25,000 and 34,000 Preferred C shares converted to 2,370,696 Common shares for the three month period ended December 31, 2019. For the six month period ended December 31, 2019, there were 89,100 Preferred C shares issued for net proceeds of $70,000 and 104,000 Preferred C shares converted to 5,595,339 Common shares.
Series C mandatory redeemable convertible preferred stock [Member] | Minimum [Member]
Dividend percent	105.00%
Series C mandatory redeemable convertible preferred stock [Member] | Maximum [Member]
Dividend percent	130.00%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	1 Months Ended
	Jan. 16, 2020	Jan. 21, 2020	Dec. 31, 2019	Jun. 30, 2019
Subsequent Event (Textual)
Shares of common stock issued			281,965,822	264,648,821
Common stock par value			$ 0.001	$ 0.001
Subsequent Event [Member]
Subsequent Event (Textual)
Shares of common stock issued		28,525,000
Shares of preferred shares converted into common stock	17,700
Shares of common shares converted into common stock	2,445,395
Issued cash	$ 570,500
Issued shares	28,525,000